Drug Type Neural stem cell therapy |
Synonyms CTX0E03- REN001 |
Target- |
Action- |
Mechanism Stem cell replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic cerebrovascular accident | Phase 2 | United States | 31 Aug 2018 | |
Brain Infarction | Phase 2 | United Kingdom | 01 Jun 2014 | |
Hemiparesis | Phase 2 | United Kingdom | 01 Jun 2014 | |
Hemiparesis | Phase 2 | United Kingdom | 01 Jun 2014 | |
Ischemic stroke | Phase 2 | United Kingdom | 01 Jun 2014 | |
Ischemic stroke | Phase 2 | United Kingdom | 01 Jun 2014 | |
Paresis | Phase 2 | United Kingdom | 01 Jun 2014 | |
Paresis | Phase 2 | United Kingdom | 01 Jun 2014 |
Phase 2 | 23 | (btnrjwtipq) = only in pts with residual upper limb movement at baseline(1 pt at at 3 months;3 pts at 6 and 12 months) ajqkdzmksk (qfcgovbitd ) | Positive | 01 Apr 2020 | |||
Phase 1 | 11 | (ynojabfrmy) = qfhuompiwa sdejatqdfj (czopdjdlzv ) View more | Positive | 20 Aug 2016 |